Incyte Corporation (INCY)
NASDAQ: INCY · IEX Real-Time Price · USD
65.87
+0.50 (0.76%)
At close: Jul 19, 2024, 4:00 PM
66.05
+0.18 (0.27%)
Pre-market: Jul 22, 2024, 7:09 AM EDT
Incyte Revenue
Incyte had revenue of $3.77B in the twelve months ending March 31, 2024, with 8.58% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $880.89M with 8.93% year-over-year growth. In the year 2023, Incyte had annual revenue of $3.70B with 8.87% growth.
Revenue (ttm)
$3.77B
Revenue Growth
+8.58%
P/S Ratio
3.93
Revenue / Employee
$1,492,815
Employees
2,524
Market Cap
14.81B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.70B | 301.01M | 8.87% |
Dec 31, 2022 | 3.39B | 408.37M | 13.67% |
Dec 31, 2021 | 2.99B | 319.57M | 11.98% |
Dec 31, 2020 | 2.67B | 507.94M | 23.53% |
Dec 31, 2019 | 2.16B | 276.88M | 14.71% |
Dec 31, 2018 | 1.88B | 345.67M | 22.50% |
Dec 31, 2017 | 1.54B | 430.50M | 38.93% |
Dec 31, 2016 | 1.11B | 351.97M | 46.70% |
Dec 31, 2015 | 753.75M | 242.26M | 47.36% |
Dec 31, 2014 | 511.50M | 156.55M | 44.10% |
Dec 31, 2013 | 354.95M | 57.89M | 19.49% |
Dec 31, 2012 | 297.06M | 202.60M | 214.50% |
Dec 31, 2011 | 94.46M | -75.42M | -44.40% |
Dec 31, 2010 | 169.88M | 160.61M | 1,733.55% |
Dec 31, 2009 | 9.27M | 5.35M | 136.41% |
Dec 31, 2008 | 3.92M | -30.52M | -88.62% |
Dec 31, 2007 | 34.44M | 6.80M | 24.59% |
Dec 31, 2006 | 27.64M | 19.80M | 252.32% |
Dec 31, 2005 | 7.85M | -6.30M | -44.54% |
Dec 31, 2004 | 14.15M | -27.05M | -65.66% |
Dec 31, 2003 | 41.20M | -54.28M | -56.85% |
Dec 31, 2002 | 95.47M | -123.79M | -56.46% |
Dec 31, 2001 | 219.26M | 25.10M | 12.92% |
Dec 31, 2000 | 194.17M | 37.21M | 23.70% |
Dec 31, 1999 | 156.96M | 22.15M | 16.43% |
Dec 31, 1998 | 134.81M | 44.82M | 49.80% |
Dec 31, 1997 | 90.00M | 48.10M | 114.81% |
Dec 31, 1996 | 41.90M | 29.68M | 243.06% |
Dec 31, 1995 | 12.21M | 10.70M | 707.67% |
Dec 31, 1994 | 1.51M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Molina Healthcare | 35.85B |
Viatris | 15.36B |
Labcorp Holdings | 12.30B |
Quest Diagnostics | 9.29B |
BeiGene | 2.76B |
United Therapeutics | 2.50B |
BioMarin Pharmaceutical | 2.47B |
Neurocrine Biosciences | 1.98B |
INCY News
- 13 days ago - Incyte to Report Second Quarter Financial Results - Business Wire
- 13 days ago - Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 19 days ago - This CrowdStrike Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
- 5 weeks ago - Incyte Announces Final Results of Tender Offer - Business Wire
- 5 weeks ago - Incyte Announces Preliminary Results of Tender Offer - Business Wire
- 6 weeks ago - Malignant Mesothelioma Pipeline Landscape Analysis, 2024 - Incyte's INCB001158 and Polaris' Pegargiminase Lead the Way in Mechanism-Specific Interventions - GlobeNewsWire
- 7 weeks ago - Incyte Completes Acquisition of Escient Pharmaceuticals - Business Wire
- 2 months ago - Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings - Business Wire